NMSIC Co-Investment Fund, L.P. 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 4:15 pm Sale | 2025-03-25 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 1,758,958 9.830% | -350,000 (-16.60%) | Filing |
| 2025-01-29 7:00 pm Sale | 2024-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,108,958 11.960% | -200,000 (-8.66%) | Filing |
| 2024-01-22 4:15 pm Unchanged | 2023-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,308,958 13.550% | 0 (Unchanged) | Filing |
| 2023-02-02 4:16 pm Unchanged | 2022-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,308,958 14.150% | 0 (Unchanged) | Filing |
| 2022-02-10 4:15 pm Unchanged | 2021-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,308,958 14.280% | 0 (Unchanged) | Filing |
| 2021-02-11 4:15 pm Sale | 2020-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,308,958 18.250% | -125,000 (-5.14%) | Filing |
| 2020-09-18 4:46 pm Purchase | 2020-09-01 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,433,958 19.260% | 2,433,958 (New Position) | Filing |